Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000202672 | SCV000257834 | benign | not specified | 2015-07-10 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000202672 | SCV000337722 | likely benign | not specified | 2015-12-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080665 | SCV000652613 | benign | Combined immunodeficiency due to LRBA deficiency | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000659004 | SCV000780807 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | LRBA: BS2 |
Gene |
RCV000659004 | SCV001872970 | uncertain significance | not provided | 2021-04-21 | criteria provided, single submitter | clinical testing | Identified in two consanguinious LRBA-deficient siblings in the published literature with primary immunodeficiency who also had a homozygous frameshift variant in the LRBA gene that was believed to be the cause of their symptoms (Seidel et al., 2015); Identified in multiple affected relatives in a large pedigree in the published literature with Hirschsprung disease in addition to a relative with functional constipation and multiple unaffected relatives (Sribudiani et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 25539626, 29601828) |
Genetic Services Laboratory, |
RCV000202672 | SCV002064858 | likely benign | not specified | 2019-12-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003927868 | SCV004738366 | likely benign | LRBA-related disorder | 2022-05-19 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000508598 | SCV000328914 | uncertain significance | Hirschsprung disease, susceptibility to, 1 | 2016-11-18 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000659004 | SCV001932395 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000659004 | SCV001970695 | likely benign | not provided | no assertion criteria provided | clinical testing |